San Francisco Chronicle

Antibodies in recovered victums’ blood may hold key to COVID-19 cure

In the race to develop treatments for the coronavirus, two California biotech companies are teaming up to collect blood samples from people who have
recovered from COVID-19 — with the hope that antibodies produced by their immune system after being infected can provide the key to developing a drug or vaccine.

Read the entire artcile here: